Multiplikator Forward P/S: Silk Road Medical (SILK)

Silk Road Medical, Inc - logo grafis emiten SILK

Silk Road Medical, Inc. (SILK) implements the unique TCAR minimally invasive technique to combat strokes, leveraging a powerful scientific and technical foundation. US plants ensure the production of carotid artery revascularization systems. The forward P/S trajectory visualizes the impact of these factors, where the value of 5.80 characterizes this level. Growing demand among surgeons due to an aging population supports the company's market positions.

silkroadmed.com - Kapitalisasi marang prakiraan pendapatan SILK (periode 04.07.2022 - 28.09.2024)

Ringkesan rincian data analitis Silk Road Medical, Inc (SILK)

- rega pasar lan target rega analis:
Analisis fundamental perusahaan:SILK (Silk Road Medical Inc.)
Sampel barang Silk Road Medical Inc

This ratio assesses the market value of the asset relative to expected earnings, demonstrating the premium investors are willing to pay per unit of future revenue. The current 5.80 value of the forward price-to-sales ratio reflects the market's priced-in expectations for the expansion of Silk Road Medical, Inc (SILK) and its unique TCAR technology, which creates a technological barrier for competitors in the stroke prevention segment.

Karo sapa Silk Road Medical, Inc saingan

Rasio rega marang prakiraan pendapatan Dexcom CGM DXCM|Penumbra Corp (PEN) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Novanta Inc - Multiplikator Forward P/S|HAE (Haemonetics Corporation) - Kapitalisasi marang prakiraan pendapatan|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PRCT|CNMD (CONMED Inc.) - Multiplikator Forward P/S|Pulse Corp (PLSE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S INMD|Multiplikator Forward P/S picardmedical.com (PMI)|Multiplikator Forward P/S SRDX (surmodics.com)|Multiplikator Forward P/S Senseonics Holdings, Inc. SENS|NPCE - Rasio rega marang prakiraan pendapatan|TCMD: Rasio rega marang prakiraan pendapatan|SNWV (Sanuwave Health Inc) - Multiplikator forward rega marang pendapatan|Prakiraan rega marang pendapatan Outset Medical OM|ELMD (SmartVest) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep LENSAR Inc. LNSR|Rasio rega marang prakiraan pendapatan AVITA Medical Inc. (RCEL)|Profound Medical Corporation (PROF) - Prakiraan rega marang pendapatan|Baird Medical Investment Holdings - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S EDAP Medical EDAP|Apyx Medical Corp - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake IceCure Medical ICCM|Pulmonx (LUNG) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan TELA (TELA Bio Corp)|Rasio rega marang prakiraan pendapatan cytosorbents.com|Multiplikator forward rega marang pendapatan Sensus Healthcare, Inc. (SRTS)|Multiplikator Forward P/S ZYXI|ECOR - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan vicarioussurgical.com RBOT|IINN: Kapitalisasi marang prakiraan pendapatan|ICU - Rasio rega marang prakiraan pendapatan|iridex.com - Rasio rega marang pendapatan sing dikarepake|INBS: Multiplikator Forward P/S|XAIR (Beyond Air Inc) - Rasio rega marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan Profusa, Inc.|SSKN (strataskinsciences.com) - Rasio rega marang pendapatan sing dikarepake|Multiplikator forward rega marang pendapatan GCTK (GlucoTrack Inc.)|nanovibronix.com - Kapitalisasi marang prakiraan pendapatan|venusconcept.com - Multiplikator forward rega marang pendapatan|Nuwellis Inc (NUWE) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|AEMD - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Asensus Surgical Inc ASXC|AVGR: Multiplikator Forward P/S|Prakiraan rega marang pendapatan BioSig Technologies, Inc. BSGM|Multiplikator forward rega marang pendapatan CUTR|Rasio rega marang prakiraan pendapatan KNW|Multiplikator Forward P/S NARI|NVRO - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan ReShape Lifesciences Inc RSLS